BIRC5 and neoplasm: The impressive reduction of tumour cell viability and the anti-apoptotic effects of single agent YM155 in DDLPS and PLS cells as well as the potential function as a drug sensitizer challenged in our experiments highlights its potential of targeting survivin in LPS.